Nasdaq:US$13.53 (-0.37) | HKEX:HK$21.60 (-0.85) | AIM:£2.01 (-0.06)
Search Result
Previous Article   |   Next Article
Scientific Publications | 4 Jun 2021

ASCO 2021: A Multicenter Open-Label Phase 1 Study Evaluating the Safety and Tolerability of HMPL-306 in Patients with Locally Advanced or Metastatic Solid Tumors with IDH Mutations